Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

doctor payments

- PMLiVE

It’s time for pharma companies to become household names

And then the sector can become meaningful to the lives of ‘ordinary’ people

- PMLiVE

Counting down to the EFPIA Disclosure Code

Communications director Andy Powrie-Smith on why the Code is part of pharma's 'licence to operate'

- PMLiVE

Could EFPIA’s new code boost pharma’s reputation?

Rule changes for payments to doctors could present the industry with an opportunity

- PMLiVE

Industry files complaint against France’s off-label law

Protests against promotion of Roche's Avastin as cheap eye medication

- PMLiVE

EFPIA’s Richard Torbett to move to the ABPI

Will take up commercial role at UK pharma bodyat the end of the month

- PMLiVE

Creating stability with medicines framework

The deals secure stability for both industry and governments

- PMLiVE

Transparency debate extends to rejected drug applications

Claims from the BMJ made in new published study

EU flag

Mid-sized European biotechs ‘need more support’

New report finds that the industry is fairing better in the US than in the EU

EU flag

EMA to stop ‘revolving doors’ committee members

Comes nearly five years after its former director left for a pharma service firm

- PMLiVE

Payment to docs rules ‘an opportunity for pharma’

The industry’s reputation can be boosted by openness, say pharma compliance leaders

- PMLiVE

WHO calls for publication of previously unreported studies

Organisation claims results from clinical trials should be reported within 12 months

- PMLiVE

SEC calls for greater disclosure from pharma

Claims companies are leaving themselves open to enforcement action

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links